Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2021 5
2022 10
2023 13
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Results by year

Filters applied: . Clear all
Page 1
Timing of cutaneous immune-related adverse events impacts survival in patients with cancer treated with immune-checkpoint inhibitors: A multi-institutional cohort study.
Rashdan H, Zhang S, Wan G, Nguyen N, Roster K, Rajeh A, Tang K, Chen W, Moseley C, Chen S, LeBoeuf N, Semenov YR. Rashdan H, et al. J Am Acad Dermatol. 2024 May;90(5):1080-1083. doi: 10.1016/j.jaad.2024.01.038. Epub 2024 Jan 28. J Am Acad Dermatol. 2024. PMID: 38290617 No abstract available.
Pre-existing inflammatory disease predicts cutaneous immunotherapy toxicity development: A multi-institutional cohort study.
Wan G, Nguyen N, Leung BW, Rashdan H, Tang K, Roster K, Collier MR, Ugwu-Dike PO, Raval NS, Alexander NA, Jairath R, Phillipps J, Amadife M, Zhang S, Gusev A, Chen ST, Reynolds KL, LeBoeuf NR, Kwatra SG, Semenov YR. Wan G, et al. J Am Acad Dermatol. 2024 Feb;90(2):418-420. doi: 10.1016/j.jaad.2023.09.082. Epub 2023 Oct 13. J Am Acad Dermatol. 2024. PMID: 37838257 No abstract available.
Development and validation of time-to-event models to predict metastatic recurrence of localized cutaneous melanoma.
Wan G, Leung BW, DeSimone MS, Nguyen N, Rajeh A, Collier MR, Rashdan H, Roster K, Zhou X, Moseley CB, Nirmal AJ, Pelletier RJ, Maliga Z, Marko-Varga G, Németh IB, Tsao H, Asgari MM, Gusev A, Stagner AM, Lian CG, Hurlbert MS, Liu F, Yu KH, Sorger PK, Semenov YR. Wan G, et al. J Am Acad Dermatol. 2024 Feb;90(2):288-298. doi: 10.1016/j.jaad.2023.08.105. Epub 2023 Oct 4. J Am Acad Dermatol. 2024. PMID: 37797836
Underuse of sentinel lymph node biopsy for early-stage melanoma.
Rajeh A, Wan G, Roster K, Rashdan H, Seo J, Nguyen N, Collier MR, Leung BW, Semenov YR. Rajeh A, et al. J Am Acad Dermatol. 2023 Oct;89(4):803-806. doi: 10.1016/j.jaad.2023.05.035. Epub 2023 May 26. J Am Acad Dermatol. 2023. PMID: 37244413 Free PMC article. No abstract available.
Increased risk of cutaneous immune-related adverse events in patients treated with talimogene laherparepvec and immune checkpoint inhibitors: A multi-hospital cohort study.
Leung BW, Wan G, Nguyen N, Rashdan H, Zhang S, Chen W, Cohen S, Boland GM, Sullivan RJ, Fadden RM, Kaufman HL, Kwatra SG, LeBoeuf NR, Semenov YR. Leung BW, et al. J Am Acad Dermatol. 2023 Jun;88(6):1265-1270. doi: 10.1016/j.jaad.2023.02.017. Epub 2023 Mar 21. J Am Acad Dermatol. 2023. PMID: 36944564 Free PMC article.
Influence of melanoma type on incidence and downstream implications of cutaneous immune-related adverse events in the setting of immune checkpoint inhibitor therapy.
Nguyen N, Wan G, Ugwu-Dike P, Alexander NA, Raval N, Zhang S, Jairath R, Phillipps J, Leung B, Roster K, Seo J, Lu C, Tang K, Choi MS, DeSimone MS, Theodosakis N, Amadife M, Cox N, Le TK, Liu F, Chen W, Bai X, Boland G, Liu D, Hurlbert MS, LeBoeuf N, Reynolds KL, Yu KH, Tsao H, Asgari M, Gusev A, Kwatra SG, Semenov YR. Nguyen N, et al. J Am Acad Dermatol. 2023 Jun;88(6):1308-1316. doi: 10.1016/j.jaad.2023.02.014. Epub 2023 Feb 22. J Am Acad Dermatol. 2023. PMID: 36828138 Free PMC article.
Tumor-infiltrating lymphocytes as a predictive biomarker of cutaneous immune-related adverse events after immune checkpoint blockade in patients with advanced melanoma.
Stephens MR, Asdourian MS, Jacoby TV, Shah N, Thompson LL, Otto T, Semenov YR, Reynolds KL, Sullivan RJ, Foreman RK, Chen ST. Stephens MR, et al. J Am Acad Dermatol. 2023 Jul;89(1):140-142. doi: 10.1016/j.jaad.2023.01.040. Epub 2023 Feb 15. J Am Acad Dermatol. 2023. PMID: 36806644 Free PMC article. No abstract available.
Patterns in utilization of health care services and medications among patients with cutaneous immune-related adverse events: A population-level cohort study.
Leung BW, Collier MR, Tiu BC, Wan G, Nguyen N, Tang K, Zhang S, Chen W, Chen ST, LeBoeuf NR, Semenov YR. Leung BW, et al. J Am Acad Dermatol. 2023 May;88(5):1215-1218. doi: 10.1016/j.jaad.2022.12.042. Epub 2023 Feb 9. J Am Acad Dermatol. 2023. PMID: 36774303 Free PMC article. No abstract available.
24 results